Literature DB >> 12875972

The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.

Jun Sato1, Jeffrey Schorey, Victoria A Ploplis, Erijka Haalboom, Liana Krahule, Francis J Castellino.   

Abstract

The fibrinolytic system is known to play an important role in the inflammatory response to bacterial infections. In the present study, relationships between protein components of the fibrinolytic system and infectivity by Mycobacterium avium were analyzed. Infections were initiated through noninvasive intratracheal administration of M. avium 724 in mice individually deficient for plasminogen, tissue-type plasminogen activator, urokinase-type plasminogen activator, and urokinase-type plasminogen activator receptor, along with wild-type control mice. There were no differences in lung colony counts among all mouse genotypes throughout a 10-week infection. However, in tissue-type plasminogen activator and plasminogen-deficient mice an earlier dissemination of M. avium to other organs was observed. Nevertheless, the M. avium growth rates in the liver, spleen, and lung did not differ between the various mouse populations throughout a 10-week infection. Histochemical and immunohistochemical analyses at 5 and 10 weeks after infection demonstrated that plasminogen-deficient mice, compared to wild-type mice, had enhanced fibrin and fibronectin deposition, as well as increased neutrophil infiltration within liver granulomas. These results suggest that plasmin(ogen) plays a role in the turnover of extracellular matrix proteins within granulomas and has a limited effect in the early dissemination of M. avium from lungs. Thus, plasmin(ogen) functions in limiting progressive fibrosis in the granuloma during a chronic mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875972      PMCID: PMC1868210          DOI: 10.1016/S0002-9440(10)63680-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  61 in total

1.  Mycobacterial infection of macrophages results in membrane-permeable phagosomes.

Authors:  R Teitelbaum; M Cammer; M L Maitland; N E Freitag; J Condeelis; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Induction of anti-mycobacterial and anti-listerial activity of human monocytes requires different activation signals.

Authors:  G Zerlauth; M M Eibl; J W Mannhalter
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.

Authors:  A R Mackay; R H Corbitt; J L Hartzler; U P Thorgeirsson
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

4.  PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.

Authors:  A Berge; U Sjöbring
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

5.  Role of the pleiotropic effects of plasminogen deficiency in infection experiments with plasminogen-deficient mice.

Authors:  J D Goguen; T Bugge; J L Degen
Journal:  Methods       Date:  2000-06       Impact factor: 3.608

6.  Interaction of Mycobacterium avium complex with human respiratory epithelial cells.

Authors:  V M Reddy; B Kumar
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

Review 7.  The cell biology of the plasminogen system.

Authors:  E F Plow; T Herren; A Redlitz; L A Miles; J L Hoover-Plow
Journal:  FASEB J       Date:  1995-07       Impact factor: 5.191

8.  Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor.

Authors:  L A Miles; C M Dahlberg; J Plescia; J Felez; K Kato; E F Plow
Journal:  Biochemistry       Date:  1991-02-12       Impact factor: 3.162

9.  Memory T cell-mediated resistance to Mycobacterium tuberculosis infection in innately susceptible and resistant mice.

Authors:  R D Hubbard; C M Flory; F M Collins
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

10.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Infectious disease, the innate immune response, and fibrosis.

Authors:  Alessia Meneghin; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 2.  A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.

Authors:  Hannah Tomlin; Anna M Piccinini
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

3.  Mycobacterium avium uses apoptotic macrophages as tools for spreading.

Authors:  Julie Early; Kay Fischer; Luiz E Bermudez
Journal:  Microb Pathog       Date:  2010-12-15       Impact factor: 3.738

4.  Expression and arrangement of extracellular matrix proteins in the lungs of mice infected with Paracoccidioides brasiliensis conidia.

Authors:  Angel González; Henrique Leonel Lenzi; Ester Maria Motta; Luzia Caputo; Angela Restrepo; Luz Elena Cano
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

5.  The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study.

Authors:  Pawan Vasudeva; Dharamveer Singh; Apul Goel
Journal:  Indian J Urol       Date:  2008-07

Review 6.  Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.

Authors:  Sarbani Bhattacharya; Victoria A Ploplis; Francis J Castellino
Journal:  J Biomed Biotechnol       Date:  2012-10-14

7.  Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.

Authors:  Mary A De Groote; Payam Nahid; Leah Jarlsberg; John L Johnson; Marc Weiner; Grace Muzanyi; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.